500 women join Australia's landmark maternity medical device study
SYDNEY, April 19, 2023 /PRNewswire/ — Medical device company Baymatob has successfully completed one of Australia’s largest maternity health studies...
Stay updated with breaking news from Breakthrough Device. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SYDNEY, April 19, 2023 /PRNewswire/ — Medical device company Baymatob has successfully completed one of Australia’s largest maternity health studies...
/PRNewswire/ -- Medical device company Baymatob has successfully completed one of Australia's largest maternity health studies for a medical device, enrolling...
/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA granted...
The Centers for Medicare & Medicaid Services (CMS or Agency) on April 10, 2023, published its annual proposed rule for the federal fiscal year (FY) 2024 Inpatient Prospective Payment...
Designation represents progress for patients with suspected Coronary Microvascular Dysfunction as the FDA recognizes disease’s debilitating impacts and the lack of effective non-invasive options for efficient diagnosis